MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2009.06.011

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2009

Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome.

Rautou Pierre-Emmanuel, Moucari Rami, Cazals-Hatem Dominique, Escolano Sylvie, Denié Cécile, Douarin Ludivine, Francoz Claire, Durand François, Ozenne Violaine, Imbert Audrey, Moreau Richard, Lebrec Didier, Plessier Aurélie, Valla Dominique

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND & AIMS: Patients with Budd-Chiari syndrome can present with acute, subacute, or chronic disease; the definitions and significance of these variants have been disputed. An increased level of serum alanine aminotransferase (ALT) is an objective marker for acute liver injury. We analyzed the significance of changes in ALT levels in Budd-Chiari syndrome patients.

METHODS

We performed a retrospective analysis of data from 96 consecutive Budd-Chiari syndrome patients.

RESULTS

A threshold peak ALT level that was 5-fold the upper limit of normal distinguished 2 groups of patients: patients with high levels of ALT (40% of patients) presented with more severe liver disease, less frequent liver fibrosis, and more frequent liver cell necrosis, compared with those with ALT levels below this threshold. Patients with levels of ALT that started out high but slowly declined (<50% of starting concentration within 3 days) had significantly lower odds of survival than those with a rapid decline and those with low levels of ALT (40 months transplantation-free survival, 31%, 63%, and 71%, respectively). When ALT level and the velocity of its decline are used as criterion, these data add significant prognostic information to Child-Pugh, to Clichy, and to Rotterdam Budd-Chiari syndrome scores.

CONCLUSIONS

Determination of ALT levels at patient presentation allows 2 variants of Budd-Chiari syndrome to be distinguished. High levels of ALT reflect acute, severe, but potentially reversible, ischemic liver cell necrosis. High levels of ALT that decrease slowly predict a poor outcome for patients and might justify rapid aggressive management.

Для цитирования: Rautou Pierre-Emmanuel, Moucari Rami, Cazals-Hatem Dominique, Escolano Sylvie, Denié Cécile, Douarin Ludivine, Francoz Claire, Durand François, Ozenne Violaine, Imbert Audrey, Moreau Richard, Lebrec Didier, Plessier Aurélie, Valla Dominique. Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2009. DOI: 10.1016/j.cgh.2009.06.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.